Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
business
business sponsored company news
fda
alnylam pharmaceuticals
ambys medicines
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
articles containing video clips
athenex
biomarin pharmaceutical
bluebird bio
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
centers for medicare & medicaid services
chris collins
cisa
clinical trials
colloids
column
competitive generic therapy
coronavirus
covid-19
cystic fibrosis
deals
detroit blog main
detroit top stories
dosage forms
drug delivery devices
gels
gene therapy
gout
health
health insurance
healthcare
hemophilia
histopathology
illumina
What
patients
6
×
separate
6
×
drug
medical
risk
absorbable
announced
announces
aren’t
augmenix
cancer
company
data
develops
drugs
help
hydrogel
hydrogels
long
manufactures
medicare
organs
press
proprietary
prostate
protect
radiotherapy
release
sells
spaceoar
technology
achieving
actually
administration
advisories
agency
alarm
align
analyzed
benefits
Language
unset
Current search:
separate
×
patients
×
@techcrunch.com
12 months ago
Critical-rated security flaw in Illumina DNA sequencing tech exposes patient data
@bgr.com
3 years ago
A drug thought to worsen coronavirus infections might actually help people recover
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@venturebeat.com
6 years ago
Augmenix Announces First Prostate Cancer Patients Treated with SpaceOAR® Hydrogel in Israel
@venturebeat.com
7 years ago
Augmenix Announces Positive Three-Year Long-Term Data Highlighting Benefits of SpaceOAR® Hydrogel Spacer for Patients with Prostate Cancer
@techcrunch.com
8 years ago
Fee-For-Value Drives Trillion-Dollar Healthcare Opportunity